Rising cell-free DNA level tracks cancer-associated methylation signal and improves multicancer detection
En palabras de los autores
Cancer patients carry more circulating cell-free DNA (ccfDNA)—small DNA fragments shed into the blood—than healthy people. Most of this excess comes not from the tumor itself but from immune cells, suggesting that it would simply dilute the much smaller amount of tumor-derived DNA in a blood sample. Using a study of 1,480 previously untreated participants across 43 hospitals—including patients with 14 cancer types spanning all stages, patients with benign growths, and healthy volunteers—we show the opposite: as total ccfDNA rises, it becomes enriched, not diluted, in fragments carrying cancer-associated DNA methylation signatures, independent of cancer type, disease stage, and a broad panel of demographic, clinical, and technical covariates. In fact, total ccfDNA explains more variance in cancer-associated methylation signal than the disease stage itself. This basic biological finding suggests a coupling between immune cell activity and tumor methylation. It also has a practical implication: we show that rising ccfDNA concentration is associated with higher cancer detection sensitivity, even within disease stages and particularly in early-stage disease—stage I sensitivity varied from 0.55 in the lowest ccfDNA concentration tertile to 0.85 in the highest, and stage II from 0.59 to 0.86. This suggests that ccfDNA concentration should be considered as a stage-independent stratification variable for benchmarking cancer-detection tests. Interestingly, similar behavior was observed in patients with symptomatic benign lesions, suggesting a broader biological response to abnormal tissue growth and not something unique to malignancy.
En palabras simples Resumen con IA
Las personas con cáncer tienen más ADN libre en la sangre que las personas sanas. Los científicos esperaban que este ADN extra ocultara la pequeña cantidad de los tumores. En cambio, encontraron que un ADN total más alto en realidad lleva más señales de cáncer. Esto se mantuvo en los 14 tipos de cáncer y en todas las etapas de la enfermedad. Los niveles más altos de ADN mejoraron la detección de cáncer, especialmente en etapas tempranas. El mismo patrón apareció en pacientes con crecimientos no cancerosos.
Escrito por Kimi K2.5 usando solo el abstract de arriba. Jev verificó que cada oración esté respaldada por las oraciones del abstract que cita y eliminó las que no. Pasá el cursor por una oración para ver de dónde sale.
Apareció: jueves, 5 de noviembre. Proceedings of the National Academy of Sciences. Revista con revisión por pares.